Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis

Blood

Volumn 93, Issue 3, 1999, Pages 796-803

  De Maria, R ^b   Testa, U ^b   Luchetti, L ^b   Zeuner, A ^b   Stassi, G ^b   Pelosi, E ^b   Riccioni, R ^b   Felli, N ^b   Samoggia, P ^b   Peschle, C ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; FAS ANTIGEN; FAS LIGAND;

ADULT; APOPTOSIS; ARTICLE; CELL MATURATION; CONTROLLED STUDY; CROSS LINKING; CYTOTOXICITY; ERYTHROBLAST; ERYTHROPOIESIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPHOBLAST; NEGATIVE FEEDBACK; PRIORITY JOURNAL;

EID: 0032950951     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.3.796     Document Type: Article

References (38)

1. Gregory CJ, Eaves AC: Three stages of erythropoietic progenitor cell differentiation distinguished by a number of physical and biologic properties. Blood 51:527, 1978
2. Krantz SB: Erythropoietin. Blood 77:419, 1991
3. Koury MJ, Bondurant MC: Erythropoietin retards DNA breakdown and prevents programmed cell death in erythroid progenitor cells. Science 248:378, 1990
4. Kelley LL, Koury MJ, Bondurant MC, Koury ST, Sawyer ST, Wickrema A: Survival or death of individual proerythroblasts results from differing erythropoietin sensitivities: A mechanism for controlled rates of erythrocyte production. Blood 82:2340, 1993
5. Gregoli PA, Bondurant MC: The roles of Bcl-XL and apopain in the control of erythropoiesis by erythropoietin. Blood 90:630, 1997
6. Reed JC: Double identity for proteins of the Bcl-2 family. Nature 387:773, 1997
7. Nagata S: Apoptosis by death factor. Cell 88:355, 1997
8. Nagata S, Golstein P: The Fas death factor. Science 267:1449, 1995
9. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J: Human ICE/CED-3 protease nomenclature. Cell 87:171, 1996
10. De Maria R, Lenti L, Malisan F, d'Agostino F, Zeuner A, Rippo MR, Tomassini B, Testi R: Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis. Science 277:1652, 1997
11. Krammer PH: The CD95(APO-1/Fas) receptor/ligand system: Death signals and disease. Cell Death Differ 3:159, 1996
12. De Maria R, Boirivant M, Cifone MG, Roncaioli P, Hahne M, Tschopp J, Pallone F, Santoni A, Testi R: Functional expression of Fas and Fas Ligand on human gut lamina propria lymphocytes. A potential role for the acidic sphingomyelinase pathway in normal immunoregulation. J Clin Invest 97:316, 1996
13. Kiener PA, Davis PM, Rankin BM, Klebanoff SJ, Ledbetter JA, Starling GC, Liles WC: Human monocytic cells contain high levels of intracellular Fas ligand. Rapid release following cellular activation. J Immunol 159:1594, 1997
14. Liles WC, Kiener PA, Ledbetter JA, Aruffo A, Klebanoff SJ: Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: Implications for the regulation of apoptosis in neutrophils. J Exp Med 184:429, 1996
15. Giordano C, Stassi G, De Maria R, Todaro M, Richiusa P, Papoff G, Ruberti G, Bagnasco M, Testi R, Galluzzo A: Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's Thyroiditis. Science 275:960, 1997
16. Griffith TS, Yu X, Herndon JM, Green D, Ferguson TA: CD95-induced apoptosis of lymphocytes in an immune-privileged site induces immunological tolerance. Immunity 5:7, 1996
17. French LE, Tschopp J: Thyroiditis and hepatitis: Fas on the road to disease. Nat Med 3:387, 1997
18. De Maria R, Testi R: Fas/FasL interactions: A common pathogenetic mechanism in organ-specific autoimmunity. Immunol Today 19:121, 1998
19. Maciejewski JP, Selleri C, Anderson S, Young NS: Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 85:3183, 1995
20. Nagafuji K, Shibuya T, Harada M, Mizuno S, Takenada K, Miyamoto T, Okamura T, Gondo H, Niho Y: Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood 86:883, 1995
21. Barcena A, Park SW, Banapour B, Muench MO, Mechetner E: Expression of Fas/CD95 and Bcl-2 by primitive hematopoietic progenitors freshly isolated from human fetal liver. Blood 88:2013, 1996
22. Dai CH, Price JO, Brunner T, Krantz SB: Fas ligand is present in human erythroid colony-forming cells and interacts with Fas induced by interferon γ to produce erythroid cell apoptosis. Blood 91:1235, 1998
23. Bernard J: The erythroblastic island: Past and future. Blood Cells 17:5, 1991
24. Hanspal M: Importance of cell-cell interactions in regulation of erythropoiesis. Curr Opin Hematol 4:142, 1997
25. Gabbianelli M, Sargiacomo M, Pelosi E, Testa U, Isacchi G, Peschle C: "Pure" human progenitors: Permissive action of basic fibroblast growth factor. Science 249:1561, 1990
26. Labbaye C, Valtieri M, Testa U, Giampaolo A, Meccia E, Sterpetti P, Parolini I, Pelosi E, Bulgarini D, Cayre YE, Peschle C: Retinoic acid downmodulates erythroid differentiation and GATA-1 expression in purified adult progenitor culture. Blood 83:651, 1994
27. Testa U, Fossati C, Samoggia P, Masciulli R, Mariani G, Hassan HJ, Sposi NM, Guerriero R, Rosato V, Gabbianelli M, Pelosi E, Valtieri M, Peschle C: Expression of growth factor receptors in unilineage differentiation culture of purified hematopoietic progenitors. Blood 88:3391, 1996
28. Condorelli G, Vitelli L, Valtieri M, Marta I, Montesoro E, Lulli V, Baer R, Peschle C: Coordinate expression and developmental role of Id2 protein and TAL1/E2A heterodimer in erythroid progenitor differentiation. Blood 86:164, 1995
29. Mariani SM, Matiba B, Baumler C, Krammer PH: Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases. Eur J Immunol 25:2303, 1995
30. Adachi M, Suematsu S, Kondo T, Ogasawara J, Tanaka T, Yoshida N, Nagata S: Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nat Genet 11:294, 1995
31. 59Fe. Br J Haematol 31:65, 1975
32. Samson D, Tikerpae J, Crowne H: A simple in vitro method for the assessment of ineffective erythropoiesis. Blood 58:782, 1981
33. Cazzola M, Guamone R, Cerani P, Centenara E, Rovati A, Beguin Y: Red blood cell precursor mass as an independent determinant of serum erythropoietin level. Blood 91:2139, 1998
34. Adachi M, Suematsu S, Kondo T, Ogasawara J, Tanaka T, Yoshida N, Nagata S: Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nat Med 11:294, 1995
35. Ossina NK, Cannas A, Powers VC, Fitzpatrick PA, Knight JD, Gilbert JR, Shekhtman EM, Tomei LD, Umansky SR, Kiefer MC: Interferon-γ modulates a p53-independent apoptotic pathway and apoptosis-related gene expression. J Biol Chem 272:16351, 1997
36. Maciejewski JP, Selleri C, Sato T, Anderson S, Young NS: Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia. J Haematol 91:245, 1995
37. Young NS, Maciejewski J: The pathophysiology of acquired aplastic anemia. N Engl J Med 336:1365, 1997
38. Rathbun RK, Faulkner GR, Ostroski MH, Christianson TA, Hughes G, Jones G, Cahn R, Maziarz R, Royle G, Keeble W, Heinrich MC, Grompe M, Tower PA, Bagby GC: Inactivation of the Fanconi anemia group C gene augments interferon-γ-induced apoptotic responses in hematopoietic cells. Blood 90:974, 1997